March 2017 | CrossLife founder & Chief Executive Officer, Dr. HyunDae Cho has been asked to serve on Special Emphasis Review Panel by the National Institutes of Health (U.S. NIH), Bioanalytical Chemistry, Biophysics, and Assay Development...